SCHEMBL5724282

SCHEMBL5724282

CC(C)(C)C1CN(c2nc(C(=O)N3CCC3)cs2)C1O[SiH](c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 7/20 0.37
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ATM Q13315 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TRPC3 Q13507 2/20 0.35
TRPC6 Q9Y210 2/20 0.35
USP30 Q70CQ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5724210 0.98 NPC1 (0.38) HTR2CNPC1ALDH1A1HPGDALOX15
SCHEMBL5724200 0.97 MEN1 (0.39) HTR2CNPC1ALDH1A1HPGDALOX15
SCHEMBL5724456 0.94 HTR2C (0.45) HTR2CNPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL5724416 0.93 HTR2C (0.36) HTR2CNPC1ALDH1A1HPGDALOX15
SCHEMBL5724120 0.93 TSHR (0.38) HTR2CNPC1ALDH1A1HPGDRAB9A
SCHEMBL5724523 0.89 RIPK1 (0.35) HTR2CHCRTR1HCRTR2MEN1KMT2A
SCHEMBL5724737 0.88 LDHA (0.41) ALDH1A1L3MBTL1KDM4E
SCHEMBL5724075 0.86 SCD (0.40) HCRTR1HCRTR2USP30
SCHEMBL5723868 0.83 NPC1 (0.41) NPC1ALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL5724321 0.83 TDP1 (0.42) NPC1ALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1340757-B1 1-METHYLCARBAPENEM DERIVATIVES SANKYO CO (JP) 2006-10-11 EP disclosed
US-7001897-B2 1-methylcarbapenem derivatives SANKYO COMPANY, LIMITED (JP) 2006-02-21 US disclosed
US-20040014962-A1 1-Methylcarbapenem derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-22 US disclosed
EP-1340757-A1 1-METHYLCARBAPENEM DERIVATIVES Sankyo Company, Limited (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014962-A1 1-Methylcarbapenem derivatives CD14, CPT1A, ACMSD HTR2C 4623/4885NPC1 383/4885ALDH1A1 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.